Zeverijn LJ, Looze EJ, Thavaneswaran S, van Berge Henegouwen JM, et al. Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials. Int J Cancer 2023;153:1413-1422.
PMID: 37424386